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INTRODUCTION
Studies in heart development have elucidated many crucial factors
involved in mediating cell fate decisions. These include diffusible
factors, such as Wnts, activin/nodal, BMPs and Noggin, that
influence the establishment of cell fate gradients in the developing
embryo. The heart, blood and vasculature are coordinately specified
from a common origin: the lateral plate mesoderm (Kattman et al.,
2006). Mounting evidence suggests that persistent Wnt/β-catenin
signaling, together with other factors, such as vascular endothelial
growth factor (VEGF), subsequently directs mesoderm into a
hemangioblast fate that gives rise to blood lineages and endothelium
of the posterior lateral plate (Wang et al., 2007). By contrast,
downregulation of Wnt/β-catenin signaling is required to guide
mesoderm into the cardiovascular lineages that form as bilateral
heart fields in the ventrolateral mesoderm (Ueno et al., 2007; Paige
et al., 2010).
Post-gastrulation, the pre-cardiac mesoderm gives rise to the
primordial heart in domains derived bilaterally along the anterior
ventral lateral mesoderm. These populations can give rise to all
three lineages of the heart, including cardiomyocytes, endothelial
cells and smooth muscle cells. Molecules such as Nkx2.5, Mef2c,
and the GATA factors converge to specify heart development
whereas lineage-restricted transcription factors such as Tbx5 (first
heart field) and Isl1 (second heart field) mediate later stages of
cardiac subtype specification (Yutzey and Benson, 2003; Brown et
al., 2004; Qyang et al., 2007).
Several genes have also been identified as being crucial mediators
of the lineage commitment of hemato-endothelial versus heart,
including the ETS family of transcription factors (e.g. ER71; also
known as ETV2) (Liu et al., 2012), and the well-known master
transcription factor for blood and endothelial development SCL
(TAL1) (Gering et al., 1998). Recent work by Van Handel et al., for
example, showed that the absence of SCL results in ectopic heart
development, mediated at least in part by increased expression of
canonical Wnt/β-catenin inhibitors (Van Handel et al., 2012). Their
data indicate that the expression of SCL not only establishes the
hemogenic-endothelial lineage but also is simultaneously required
to suppress the cardiogenic potential of those cells.
Although it is possible that the spatial pattern of pre-cardiogenic
cells might be specified in large part by the overlapping patterns of
soluble gradients of agonists or antagonists, we wondered whether
cell-autonomous regulators of the Wnt/β-catenin pathway might exert
fine control over the spatial domain of cardiogenic cells. This idea
has precedent, as others have shown that temporal, spatial or cell type-
dependent regulators of Wnt/β-catenin are active in embryonic
development (Martin and Kimelman, 2012). We therefore sought cell-
autonomous regulators of this pathway to investigate whether we
could identify new context-dependent regulators of Wnt/β-catenin
signaling that participate in cardiogenesis.
Human embryonic stem cell differentiation has been shown to
recapitulate in vivo heart development (Murry and Keller, 2008),
and recent work from our group has revealed an epigenetic signature
for novel regulators of this process (Paige et al., 2012). Parallel work
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SUMMARY
Genetic regulation of the cell fate transition from lateral plate mesoderm to the specification of cardiomyocytes requires suppression
of Wnt/β-catenin signaling, but the mechanism for this is not well understood. By analyzing gene expression and chromatin dynamics
during directed differentiation of human embryonic stem cells (hESCs), we identified a suppressor of Wnt/β-catenin signaling,
transmembrane protein 88 (TMEM88), as a potential regulator of cardiovascular progenitor cell (CVP) specification. During the
transition from mesoderm to the CVP, TMEM88 has a chromatin signature of genes that mediate cell fate decisions, and its expression
is highly upregulated in advance of key cardiac transcription factors in vitro and in vivo. In early zebrafish embryos, tmem88a is
expressed broadly in the lateral plate mesoderm, including the bilateral heart fields. Short hairpin RNA targeting of TMEM88 during
hESC cardiac differentiation increases Wnt/β-catenin signaling, confirming its role as a suppressor of this pathway. TMEM88 knockdown
has no effect on NKX2.5 or GATA4 expression, but 80% of genes most highly induced during CVP development have reduced
expression, suggesting adoption of a new cell fate. In support of this, analysis of later stage cell differentiation showed that TMEM88
knockdown inhibits cardiomyocyte differentiation and promotes endothelial differentiation. Taken together, TMEM88 is crucial for
heart development and acts downstream of GATA factors in the pre-cardiac mesoderm to specify lineage commitment of
cardiomyocyte development through inhibition of Wnt/β-catenin signaling.
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has also provided genome-wide transcriptional and epigenetic
analyses in mouse embryonic stem cell (ESC) cardiac
differentiation (Wamstad et al., 2012). Studies on genetic and
epigenetic changes in heart development by our laboratory revealed
a novel negative regulator of Wnt/β-catenin signaling, designated
as transmembrane protein 88 (TMEM88), that is highly expressed
during the specification of the cardiovascular progenitor cell. Aside
from its known role as a negative regulator of Wnt signaling (Lee
et al., 2010), currently there is little known about the biological
function of TMEM88 in development or adult physiology. By
studying  hESCs in vitro and zebrafish development in vivo, we
show here that TMEM88 is necessary for cardiomyocyte
specification during the early stages of heart development.
MATERIALS AND METHODS
Cell culture
RUES2 human ESCs were maintained as previously described (Paige et al.,
2012). In brief, cells were plated on Matrigel (BD Biosciences)-coated
plates and maintained in an undifferentiated state with mouse embryonic
fibroblast (MEF)-conditioned media containing 5 ng/ml human basic
fibroblast growth factor (hbFGF) (Peprotech, 100-18B).
Lentiviral transduction
Lentivirus transduction was performed in cell suspension in the presence
of 10 μM Y-27632 (Sigma). Lentiviruses were generated to express short
hairpin (sh)RNA sequences targeting various domains of the TMEM88
transcript in a PLK0.1 backbone containing a puromycin resistance cassette
(Sigma, TRCN0000178754, NM_203411.1-692s1c1; TRCN0000179147,
NM_203411.1-94s1c1; TRC0000180154, NM_203411.1-677s1c1;
TRCN0000180661, NM_203411.1-691s1c1). A lentivirus expressing a non-
targeting shRNA was used as a control (Sigma). To assess Wnt/β-catenin
signaling activity, cells were transduced with the β-catenin-activated
reporter lentivirus driving either luciferase or venus.
Human ESC directed differentiation
Cardiac differentiation was performed as previously described (Gantz et al.,
2012). In a subset of experiments, 1 μM XAV-939 (Tocris, 3748) was added
at day 3 of differentiation.
Hematopoietic differentiation on OP9 cells
Cells were cultured until day 5, at which point media was changed to
endothelial basal medium (EBM) media containing EGM BulletKit (Lonza
CC-3156) for an additional 7-9 days. OP9 feeder cells were seeded in 24-
well plates 1 day prior to co-culture. hESC-derived cells differentiated for
about 14 days were seeded onto OP9 cells at 2-8×104 cells per well in α-
MEM (Invitrogen) with 10% fetal bovine serum (FBS) (Hyclone),
penicillin/streptomycin (Invitrogen) and recombinant cytokines (from R&D
Systems unless otherwise indicated): hSCF (50 ng/ml), hTPO (20 ng/ml),
hIL-6 (20 ng/ml), hIL-3 (20 ng/ml), hFLT3L (20 ng/ml), hIL-11 (10 ng/ml),
hEPO (2 U/ml), hBMP4 (10 ng/ml), hGM-CSF (100 ng/ml), mVEGF (10
ng/ml; Peprotech). Following 5-6 days of co-culture, non-adherent/loosely
adherent cells were removed by pipetting and were passed through a 35-
μm cell strainer (BD Falcon). Cells were stained with various combinations
of the following monoclonal antibodies for cell surface analysis: APC-
conjugated anti-human CD43 (Clone 1G10, BD Pharmingen), PE-
conjugated anti-human CD235a (Clone GA-R2, BD Pharmingen),
PECy7-conjugated anti-human CD45 (Clone H130, Biolegend) and PECy7-
conjugated anti-human CD41 (Clone HIP8, Biolegend), or corresponding
isotype control antibodies. DAPI was used to exclude dead cells. Flow
cytometry was performed on a Becton Dickinson Canto 2 and data were
analyzed using FlowJo 7.6 Software.
Analysis of chromatin dynamics and gene expression during
cardiac differentiation
Data generated previously by Paige et al. (Paige et al., 2012) are deposited
in the NCBI Gene Expression Omnibus (GEO) database under accession
numbers GSE35583 for epigenetics data and GSE19090 for gene expression
data.
PCR
For quantitative PCR, total RNA was isolated using the RNeasy Miniprep
Kit (Qiagen). First-strand cDNA was synthesized using the Superscript III
enzyme kit (Invitrogen). Quantitative PCR was performed using Sensimix
SYBR PCR Kit (Bioline) on a 7900HT Fast-Real-Time PCR System
(Applied Biosystems). The copy number for each transcript is expressed
relative to that of HPRT. Quantitative PCR results are displayed as
normalized to control. Primers used for quantitative PCR are listed in
supplementary material Table S1. For standard PCR, cDNA transcripts were
amplified using GoTaq Flexi polymerase (Promega, M8291). Amplification
of TMEM88 isoforms was performed using the following primers: Forward
primer 1: GCAGCCGCGGCAAATCC; Forward primer 2: CCCGCAGC -
CGCGGCAAATCC; Reverse primer 3: GATGCTAGGACTCCGC -
TCAGGC.
Phylogenetic analysis of TMEM88 protein orthologs
Sequences were extracted by searching the NCBI protein database
(supplementary material Table S2). Protein and nucleotide sequences were
aligned by ClustalW analysis as originally described by Thompson et al.
(Thompson et al., 1994). Multiple alignment parameters were as follows:
gap penalty=15; gap length penalty=6.66; protein weight matrix: Gonnet
series. Pairwise analysis of percent identity between sequences was used to
define the relationship between proteins or within proteins across designated
species. The values computed are the mean number of differences per site
and fall between 0 and 1. Zero represents complete identity and 1 no
identity. Scale of the phylogenetic tree indicates the number of nucleotide
substitutions per 100 residues. Sequence ID and divergence values were
calculated such that divergence (i,j) is calculated as {100[distance (i,j)]/total
distance}, where (i,j) is the sum of the branch lengths between two
sequences and total distance is the sum of all branch lengths.
Gene expression analysis by array
Total RNA integrity was checked using an Agilent 2200 TapeStation
(Agilent Technologies, Santa Clara, CA, USA) and quantified using a
Trinean DropSense96 spectrophotometer (Caliper Life Sciences,
Hopkinton, MA, USA). High quality RNA samples were converted to
cDNA and biotin-labeled for microarray analysis using Ambion’s Illumina
TotalPrep RNA Amplification Kit (Life Technologies, Grand Island, NY,
USA). Labeled cRNAs were processed on a HumanHT-12 v4 Expression
BeadChip (Illumina, San Diego, CA, USA) and imaged using an Illumina
iScan system.
Microarray data analysis
The complete set of microarray data was assessed for quality, followed by
quantile normalization using the Bioconductor package lumi (Du et al.,
2008). The dataset was filtered initially by flagging probes that were below
a signal ‘noise floor’, which was established using the 75th percentile of
the negative control probe signals within each array. We subsequently
filtered the dataset by employing a variance filter using the ‘shorth’ function
of the Bioconductor package genefilter. Pair-wise statistical analyses were
performed using the Bioconductor package limma (Smyth, 2005), and a
false discovery rate (FDR) method was used to correct for multiple testing
(Reiner et al., 2003). Differential gene expression was defined as |log2
(ratio)| ≥1 (±twofold) with the FDR set to 5%. Heat maps were generated
with ‘R’ using normalized values. Differentially expressed genes were
classified according to gene ontology, using Bioconductor packages and
online tools (DAVID/EASE, http://david.abcc.ncifcrf.gov/). Microarray data
have been deposited in the NCBI GEO database under accession number
GSE43805.
Flow cytometry
Cells were labeled for flow cytometry using the following antibodies:
human anti-PDGFRα APC (R&D Systems) and human anti-VEGF
R2/KDR PE (R&D Systems). Cells were analyzed using a BD
FACSCANTO II or sorted on a BD FACSARIA II (Beckton Dickinson, San
Jose, CA, USA) with FACSDiva software (BD Biosciences). Cells were
analyzed or sorted using a 488-nm argon laser plotting PE (585/42 filter) and
a 633-nm argon laser plotting APC (660/20). Instrument settings were
RESEARCH ARTICLE Development 140 (18)
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adjusted to avoid spectral overlap. Data analysis was performed using
FlowJo (Tree Star, Ashland, OR, USA).
Luciferase reporter assays
Cells were lysed in vitro. After one freeze/thaw cycle, cell lysate was mixed
with luciferase assay reagent (Promega) and analyzed by bioluminometry
using an Envision plate reader.
Immunofluorescence
Cells were fixed in 2% paraformaldehyde, permeabilized in PBS containing
0.025% Triton X-100, and blocked in PBS containing 1.5% normal goat
serum. Cells were stained with anti-von Willibrand Factor (vWF) (1:500,
Dako) followed by secondary staining with Alexa Fluor 488 (1:200,
Molecular Probes). Nuclei were counterstained with DAPI.
Zebrafish in situ hybridization
The AB wild-type strain (Zebrafish International Resource Center, Eugene,
OR, USA) was used for all fish experiments, maintained using standard
procedures and used in accordance with Institutional Animal Care and Use
Committee-approved protocols. Brightfield in situ hybridizations for nkx2.5
and tmem88a were performed using digoxigenin-UTP labeled probes as
previously described (Thisse and Thisse, 2008) with the exception that
maleic acid buffer (MAB) was used in place of PBS in all washes between
hybridization and labeling. The nkx2.5 probe was synthesized from
published constructs (Lee et al., 1996; Yelon et al., 1999). For the tmem88a
probe, full-length mRNA sequence was PCR amplified from ATCC clone
10330432 and subcloned into the pGEM-T Easy vector (Promega). Double
fluorescent in situ hybridizations were carried out as previously described
(Welten et al., 2006), using a fluorescein-UTP-labeled tmem88a and a
digoxigenin-UTP-labeled nkx2.5 probe. Images were taken with a Nikon
SMZ1500 microscope using a Nikon Digital Sight DS-Ri1 camera.
Statistics
Single variable analysis between two samples was carried out using
Student’s t-test. Single and multivariable assays were analyzed by one- or
two-way ANOVA. Results are presented as mean±s.e.m. For all statistically
significant results, *P<0.05.
RESULTS
The cardiovascular progenitor cell population provides a potential
source of cells useful for regenerating the injured heart owing to its
capacity to give rise to multiple cardiovascular cell types, including
endothelial cells, smooth muscle cells and cardiomyocytes. Work
from our group and others has identified a biphasic role for Wnt/β-
catenin signaling during cardiovascular development, with Wnt
signals being required for mesoderm induction and their suppression
being required for emergence of cardiomyocytes (Ueno et al., 2007;
Paige et al., 2010). In the context of high-density monolayer cardiac
directed differentiation (Fig. 1A), a Wnt/β-catenin-activated reporter
(Fig. 1A) expressed in hESCs was used to assay endogenous Wnt/β-
catenin pathway activity during cardiomyocyte development. These
results show that Wnt/β-catenin signaling activity peaks at 2 days
(mesoderm) and declines significantly by day 5 when the
cardiovascular progenitor is prominent (Fig. 1C). Interestingly, the
mRNA for multiple Wnt ligands capable of activating this pathway
persisted at high levels between days 2 and 5 (Fig. 1D), suggesting
that ligand availability could not explain this decline in activity.
To gain more insight into this developmental process, gene
expression arrays and chromatin profiles recently generated by
Paige et al. (Paige et al., 2012) were analyzed to identify potential
negative regulators of Wnt/β-catenin signaling that were highly
induced during the transition of hESC derivatives from mesoderm
to the cardiac progenitor cell. The top 50 most induced genes were
collated (Fig. 1E). Transmembrane protein 88 (TMEM88) was
identified as a protein reported to negatively regulate Wnt/β-catenin
in a cell-autonomous manner and was highly induced during fate
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Fig. 1. TMEM88 is strongly activated during development of the cardiac progenitor cell when Wnt signaling is downregulated. (A) Schematic
of high-density monolayer cardiac directed differentiation of hESCs. (B) Schematic of lentiviral vector expressing β-catenin activated reporter (BAR). 
(C) BAR-luciferase measurements during cardiac differentiation of hESCs. RLU, relative light units. (D) mRNA expression of canonical Wnt ligands during
cardiac directed differentiation of hESCs. (E) Rank order of the top 50 genes most highly induced from mesoderm (day 2) to development of the CVP
(day 5). (F-J) Expression profiles by qPCR of brachury T (F), TMEM88 (G), NKX2.5 (H), TBX5 (I) and cardiac troponin T (J) during cardiac directed
differentiation of human ESCs (RUES2). (K) Chromatin immunoprecipitation/deep sequencing analysis of epigenetic histone modifications, including
H3K27me3 (red), H3K4me3 (green) and H3K36me3 (purple) around the TMEM88 locus during different cell state transitions of hESC (H7) cardiac directed
differentiation. Error bars indicate s.e.m. D
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specification of the CVP (Lee et al., 2010). We selected this gene for
further study to test the working hypothesis that TMEM88 regulates
Wnt/β-catenin signaling during cardiogenesis.
There are two TMEM88 isoforms (TMEM88 CRA_a: GI
119610530; and TMEM88 CRA_b: GI 119610531), which are
expressed from the same genomic position on human chromosome
17 (supplementary material Fig. S1A). Note that TMEM88 CRA_b
is not yet annotated and has no sequence relation to the annotated
TMEM88B gene (GI 226442743) located on human chromosome
1. TMEM88 CRA_a contains the c-terminal PDZ binding motif.
TMEM88 CRA_b has the same transcript as TMEM88 CRA_a with
the exception of a second intron starting precisely upstream of the
Val-Trp-Val PDZ binding motif and after 68 bp initiates a third exon.
As a consequence, TMEM88 CRA_b has a distinct C-terminus and
does not have the crucial PDZ binding motif known to regulate
Wnt/β-catenin signaling. To determine which isoform is expressed
during hESC cardiac differentiation, transcripts from day 5
cardiovascular progenitor cells were analyzed (supplementary
material Fig. S1B). RT-PCR was used to amplify the domain
encompassing the transcript difference between TMEM88 CRA_a
and TMEM88 CRA_b with the difference detected by variations in
nucleotide length. These data show that TMEM88 CRA_a, which
contains the PDZ binding motif, is the dominant isoform expressed
during hESC cardiac differentiation. TMEM88 CRA_a is hereafter
referred to as TMEM88.
Gene expression analysis by array as well as epigenetic chromatin
dynamics revealed a tightly regulated temporal activation profile
for TMEM88 during cardiac differentiation. By qPCR, TMEM88 is
activated shortly after the mesoderm maker brachyury (T) (Fig. 1F)
and increases during the lineage specification of the cardiovascular
progenitor cell at day 5 (Fig. 1G). TMEM88 activates prior to key
transcription factors involved in heart development, such as NKX2.5
(Fig. 1H) and TBX5 (Fig. 1I), and well in advance of myofilament
genes, such as cardiac troponin T (Fig. 1J). This places the
TMEM88 transcript temporally at a point at which it could affect the
fate of cardiovascular progenitors.
Chromatin dynamics during different stages of cardiac directed
differentiation of hESCs were acquired by chromatin
immunoprecipitation followed by deep sequencing (Paige et al.,
2012). Epigenetic analysis was performed for lysine 27
trimethylation on histone 3 (H3K27me3), which is a repressive
chromatin mark, as well as for marks of actively transcribed
chromatin as measured by lysine 4 trimethylation on histone 3
(H3K4me3) and lysine 36 trimethylation on histone 3 (H3K36me3,
a surrogate for RNA polymerase II activity) (Fig. 1K). The
TMEM88 locus at human chromosome 17p13.1 is marked by
repressive H3K27 trimethylation in the undifferentiated state (day
0) and during the transition through mesoderm lineage specification
(day 2). Consistent with gene expression array data, the activating
H3K4me3 and H3K36me3 marks remain low during pluripotency
and mesoderm specification. However, as cell fate restricts to the
cardiovascular progenitor at day 5, the repressive H3K27me3
decreases markedly, and the activating H3K4me3 state expands
(Fig. 1K). Thus, TMEM88 has a large dynamic range of RNA
expression, associated with tight regulation by repressive and
activating waves of chromatin.
In order to obtain anatomical information about the expression
pattern of TMEM88 during embryogenesis, we studied the zebrafish
ortholog tmem88a during development. In situ hybridization of
zebrafish embryos shows no expression prior to the two-somite
stage. As the lateral plate mesoderm emerges at 10.5 hours post-
fertilization (hpf) (two-somite stage), tmem88a is expressed in
bilateral ‘stripes’ ahead of other cardiac markers, such as nkx2.5
(Fig. 2A,A,F,F). At 11.5 hpf (five-somite stage), nkx2.5 emerges
in a subset of the domain outlined by tmem88a expression
(Fig. 2B,B,G,G). By 13 hpf (eight-somite stage), tmem88a marks
a broad swath of lateral plate mesoderm anterior to posterior,
extending beyond the cardiogenic mesoderm marked by nkx2.5
(Fig. 2C,C,H,H). Whole-mount analyses at 19 and 24 hpf revealed
that tmem88a is expressed within the primordial heart field but
seems to be more expansively expressed in the emerging
vasculature (Fig. 2D,E,I,J), consistent with the findings of Gomez
et al. (Gomez et al., 2012).
To gain more clarity about the localization of tmem88a in the
developing heart, double in situ hybridization was performed for
tmem88a and nkx2.5 (Fig. 2K-N). At 13 hpf, lateral and dorsal
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Fig. 2. In situ hybridization of tmem88a and nkx2.5 in developing zebrafish embryos. (A-J) tmem88a and nkx2.5 expression during early
development in zebrafish. Whole-mount in situ hybridizations for tmem88a (A-E) and nkx2.5 (F-J) were performed on embryos ranging from 10.5 hpf to
24 hpf. (K-N) Double fluorescent in situ hybridizations for nkx2.5 (green) and tmem88a (red) at 13 hpf (eight-somite stage; K,L) and 19 hpf (M,N). The
white dotted box in merged panels (K-M) outlines the region shown at 4× magnification to the right. A-J, K and M are lateral views with anterior to the
left. A-J, L and N are dorsal views with anterior to the bottom. Scale bars: in J, 200 μm for A-J; in M, 200 μm for K,M; in N, 200 μm for L,N. D
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views show that tmem88a and nkx2.5 have a clear overlap in the
emerging heart field, although tmem88a extends both anteriorly and
posteriorly from nkx2.5 (Fig. 2K,L). At 19 hpf, tmem88a is
expressed in the developing vasculature but is not expressed in
coordination with nkx2.5 in the heart (Fig. 2M,N). These data
indicate that tmem88a is expressed at a time and place where it
could regulate pre-cardiac mesoderm specification but is
downregulated at later stages of development, even as expression
increases in the developing vasculature.
Because TMEM88 is potentially a crucial regulator of CVP
differentiation, we wanted to determine whether this protein has
been conserved throughout evolution. Amino acid sequences were
compared in multiple species using known or predicted sequences
for TMEM88. Interestingly, sequences were found within the
chordate ancestry but were restricted to vertebrate species
(supplementary material Fig. S2). No orthologs were identified for
TMEM88 within any invertebrate chordates, nor were orthologs
found in insects such as Drosophila melanogaster. Sequence
percent identity and phylogenetic analysis of protein sequences
shows bird and amphibian TMEM88 diverging markedly from fish,
reptiles and mammals. Although various regions and residues
showed high sequence similarity, the C-terminal PDZ binding motif
valine-tryptophan-valine (VWV) showed high homology among all
species and perfect homology among all species for the last two
WV residues (supplementary material Fig. S2). Thus, TMEM88
protein appears as vertebrate chordates diverge from their
invertebrate counterparts, and the PDZ domain is a particularly
conserved region.
To determine whether TMEM88 is functionally required for
cardiac differentiation, two different lentiviruses were used that
express short hairpin RNA (shRNA) sequences targeting the first
exon (shRNA 94) and the 3 UTR (shRNA 691) of the TMEM88
transcript (Fig. 3A). We first sought to determine whether TMEM88
regulates Wnt pathway activity during hESC cardiovascular
differentiation. Using a BAR-venus lentiviral vector (Davidson et
al., 2012), endogenous Wnt pathway activity was analyzed to
determine an effect on Wnt/β-catenin signaling in TMEM88
knockdown (KD) cells (Fig. 3B). At day 6 of differentiation,
TMEM88 KD cells had significantly higher Wnt pathway activity
compared with controls, based on measurements of mean venus
fluorescence intensity (Fig. 3C,D). Thus, TMEM88 functions as a
negative regulator of β-catenin signaling during cardiac
differentiation.
Cells transduced with TMEM88 or control shRNAs were induced
for cardiac differentiation and samples were isolated for RNA
analysis at various time points. By quantitative RT-PCR, TMEM88
transcripts were significantly diminished throughout differentiation
in the shRNA TMEM88 cohort compared with the control shRNA
cells (Fig. 3E). Day 2 brachyury expression was not different
between control and knockdown cohorts, indicating that TMEM88
KD did not alter cell fate commitment into the mesoderm lineage
(brachyury expression with control shRNA: 1.6±0.69; versus
TMEM88 shRNA: 3.0±1.4; P=0.36). Expression of GATA4 from
day 4 to 5 was not altered by knockdown of TMEM88 (Fig. 3F),
consistent with findings by Novikov and Evans indicating that
TMEM88 acts downstream of GATA factors during cardiac
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Fig. 3. Knockdown of TMEM88
increases Wnt/β-catenin signaling
and attenuates cardiomyocyte
differentiation in vitro.
(A) Schematic of shRNA binding sites
(red bars) on the TMEM88 transcript.
(B) Schematic of BAR-venus vector. 
(C) Representative histogram of venus
activity in control versus TMEM88
shRNA populations. (D) TMEM88
expression by qPCR (left) and mean
fluorescence intensity of BAR-venus
activity (right) in control versus
TMEM88 shRNA samples. (E) Gene
expression analysis by qRT-PCR of
TMEM88 comparing TMEM88 shRNA
KD with control shRNA during 
cardiac directed differentiation. 
(F,G) Expression of GATA4 (F) and
NKX2.5 (G) in control versus TMEM88
shRNA samples by qRT-PCR during the
time course of cardiac differentiation.
(H) Validation of key cardiac genes
identified by array using qRT-PCR
analysis showing significant
downregulation of the cardiac gene
program at day 5. TMEM88 shRNA runs
n=5 from two different shRNA vectors,
control shRNA runs n=7. Error bars
represent s.e.m. *P<0.05.
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development (Novikov and Evans, 2013). Furthermore, expression
of NKX2.5 did not show a significant difference during the time
course of cardiac differentiation between TMEM88 shRNA and
control samples (Fig. 3G).
To determine the genome-wide implications for TMEM88 KD
in cardiovascular progenitor cells, RNA from day 5 of
differentiation was assayed by gene expression array. We found 298
genes that were greater than twofold differentially expressed
between control and TMEM88 shRNA samples at day 5
(supplementary material Table S3). Many genes with known
functions in cardiovascular development or function were
significantly downregulated by TMEM88 KD (supplementary
material Table S4). DAVID bioinformatics analysis of gene
ontologies downregulated in TMEM88 shRNA samples showed a
significant enrichment for genes involved in processes of solid
tissue development, such as tissue morphogenesis and extracellular
matrix, as well as a wide range of ontologies crucial for cardiac
development and function (supplementary material Table S5).
Quantitative PCR of key genes involved in heart development
analyzed at day 5 confirmed the array observations across all
TMEM88 and control shRNA samples (Fig. 3H). Analysis of array
data from control versus TMEM88 KD also revealed that
downregulation of TMEM88 resulted in reduced expression of
multiple other Wnt/β-catenin pathway regulators, including
WNT5A, DKK1 and SFRP5 (supplementary material Table S4).
Next, we analyzed the effect of TMEM88 KD on the genes
induced to the greatest extent during the lineage transition from
mesoderm to the cardiovascular progenitor cell population. Gene
expression array data at day 5 were normalized to the expression at
day 2 to define the fold induction for each gene during the transition
from mesoderm to the cardiovascular progenitor cell. The top 50
most induced genes were then analyzed by k-means clustering to
generate a heat map of chromatin and transcript expression for each
gene (Fig. 4A). This is an unbiased approach, as no pre-existing
knowledge about gene function is required to determine the rank
order. As expected, transcript expression for all genes is highly
induced at day 5, with many genes showing early repressive
chromatin, followed at later stages by activating chromatin (e.g.
TMEM88), an epigenetic signature indicative of genes involved in
mediating cell fate transitions (Fig. 4A). We consider this collection
of genes to be a molecular signature of the cardiovascular progenitor
cell, because it defines in an unbiased fashion those genes most
highly induced during the development of the CVP.
In the presence of TMEM88 shRNA, 46% of these highly
induced genes are downregulated greater than twofold, and an
additional 34% are downregulated by less than twofold (Fig. 4B).
The remaining 20% of genes had some degree of upregulation.
Linear regression analysis shows a significant (P=0.0004)
correlation between the degree of downregulation after TMEM88
KD relative to the induction level of that gene during the transition
from mesoderm to the CVP (Fig. 4C). Taken together, these data
show that TMEM88 KD results in a global downregulation of genes
that define the development of cardiovascular progenitor cells.
Because TMEM88 KD has a marked impact on cardiovascular
progenitor cell development, cells were analyzed at the day 14 time
point to determine the impact on cardiac fate. At day 14, when
beating cardiomyocytes are present in control cultures, the
TMEM88 KD cells showed a marked downregulation of markers of
definitive cardiomyocytes, including reduced expression of
myofilament and calcium handling proteins (Fig. 5A). To determine
whether the deficiency in cardiac differentiation resulting from
TMEM88 KD could be recovered by introducing an exogenous Wnt
inhibitor, XAV-939 was added at day 3 of differentiation. XAV-939
is a tankyrase inhibitor that causes increased steady state levels of
axin, thus blocking β-catenin signaling at a molecular level expected
to be downstream of TMEM88. Addition of 1 μM XAV-939 had no
effect on TMEM88 transcript levels (Fig. 5B) but partially recovered
the cardiac differentiation of cells with TMEM88 KD based on flow
cytometry analysis of cardiac troponin T (cTnT)-positive cells at
day 14 of differentiation (Fig. 5C).
We also explored whether knockdown of TMEM88 promoted
alternative lineages at the expense of cardiovascular progenitors.
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Fig. 4. TMEM88 KD results in global downregulation of genes that signify development of the CVP. (A) Chromatin profile and gene expression
from day 0 (undifferentiated state) to day 14 (mature cardiomyocyte) in wild-type cells for the top 50 most highly induced genes during development
of the CVP. (B) Array data were used to assess the impact of TMEM88 KD for all genes identified in the CVP signature. Genes were grouped by fold
change relative to control shRNA. (C) Linear regression (red line) was performed comparing the top 100 most induced genes in the CVP ranked
sequentially and analyzed against the fold change for each gene in the TMEM88 KD. D
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Bioinformatics analysis of gene ontology show that gene clusters
greater than twofold upregulated in the TMEM88 KD cells included
the Notch signaling pathway (Kim et al., 2013), EGF signaling
(Doan et al., 2013), regulation of cell proliferation, mesenchymal
and mesodermal developmental, and, most interestingly, genes
involved in hematopoiesis and blood vessel development
(supplementary material Table S6). The endothelial potential of
these cells was validated by qPCR of specific genes involved in
development of hemato-endothelial lineages (Fig. 6A). In addition
to upregulation of HHEX (a hemato-endothelial specific homeobox
gene) and OTX1 (a homeobox gene involved in hematopoiesis and
neural development), we found that SCL (TAL1), encoding a master
transcription factor that drives hemato-endothelial specification and
represses cardiomyogenesis (Gering et al., 1998; Van Handel et al.,
2012; Kim et al., 2013), was significantly increased in TMEM88
KD cohorts. SOX17, also greater than twofold upregulated in
TMEM88 KD cells, has recently been shown to be expressed in
hemogenic endothelium and emerging hematopoietic stem cells
(HSCs) and is functionally required for HSC development (Clarke
et al., 2013). Other genes with known functions in blood and
endothelial development that were twofold upregulated in
TMEM88 KD cells are listed in supplementary material Table S7.
TMEM88 KD induced striking morphological changes as well.
Whereas the cardiovascular progenitors grew as flattened
monolayers, the TMEM88 KD cells grew as networks of cell
cords/tubes, reminiscent of endothelial cell cultures on Matrigel
(Fig. 6B). Immunostaining for the endothelial marker von
Willebrand factor showed that the cellular networks were composed
almost entirely of endothelial cells (growing atop non-endothelial
cells), whereas endothelial cells were rare in the control population
(Fig. 6B). These data suggest that knockdown of TMEM88 re-
directs pre-cardiac mesodermal derivatives into an endothelial
pathway instead of the cardiomyocyte progenitor population.
Previous studies have shown that cardiac progenitors are derived
from a KDRlow, PDGFRα+ population, whereas endothelium
transitions through a KDRhigh, PDGFRα– population (Shalaby et al.,
1997; Kattman et al., 2011). We therefore sought to determine
whether endothelial cells observed in TMEM88 KD cells have a
similar phenotype. We analyzed KDR and PDGFRα expression by
flow cytometry at day 5 of cardiac differentiation and found that
control cells were KDRlow, PDGFRα+ (Fig. 6C,D). However,
TMEM88 KD cells were shifted towards KDRhigh expression with
a significant downregulation of PDGFRα, consistent with an
endothelial phenotype (Fig. 6C,D).
During in vivo development as well as ESC differentiation in
vitro, populations of endothelial cells are known to have hemogenic
potential, and this has recently been shown to be true of
cardiovascular endothelium (Van Handel et al., 2012; Nakano et al.,
2013; Rafii et al., 2013). We therefore determined whether
endothelial cells derived from TMEM88 KD could generate blood
lineages. At day 5 of differentiation, cultures were transitioned to
EGM media to facilitate endothelial development (supplementary
material Fig. S3A). After 2 weeks of differentiation, hESC-derived
cells were harvested and plated in co-culture with OP9 cells with
hematopoietic cytokines (supplementary material Fig. S3A).
Following 5 to 6 days of co-culture, non-adherent cells were
removed from co-culture and stained with the hematopoietic-
specific markers CD43 (SPN), CD235a (GYPA) and CD45
(PTPRC). Flow cytometric analysis showed no significant
expression of these markers in control cultures. However, TMEM88
KD cultures contained cells co-expressing CD43 and CD235a, a
phenotype consistent with primitive erythropoiesis (supplementary
material Fig. S3B,C) (Vodyanik et al., 2006; Rafii et al., 2013).
Some evidence of non-erythroid blood was observed in TMEM88
KD cultures based on CD45 expression, although not consistently
(data not shown). The predominance of the erythroid phenotype in
the TMEM88 KD cultures perhaps reflects the culture conditions
used or, alternatively, the known role in Wnt/β-catenin signaling in
promoting primitive erythropoiesis (Cheng et al., 2008).
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Fig. 5. TMEM88 KD attenuates cardiac maturation, which can be
rescued by exogenous Wnt inhibition. (A) Quantitative PCR of cardiac
genes at the day 14 time point comparing TMEM88 shRNA versus control
shRNA cohorts. (B,C) TMEM88 expression by qPCR at day 5 of
differentiation (B) and percentage cTnT by flow cytometry at day 14 of
differentiation (C) in control versus TMEM88 shRNA versus TMEM88
shRNA + 1 μM XAV-939. shRNA runs ± XAV-939 n=3-5 from two different
TMEM88 shRNA vectors; control shRNA runs n=5-7. Error bars represent
s.e.m. *P<0.05.
Fig. 6. Genes upregulated in TMEM88 KD cells suggest activation of
endothelial lineages. (A) Quantitative PCR analysis at day 5 and day 14
of selected genes involved in mediating endothelial cell development
and differentiation. (B) Brightfield images (top) and immunofluorescence
for vWF (bottom) of TMEM88 shRNA KD cells compared with control at
day 5. vWF, green; DAPI, blue. Scale bars: 100 μm (brightfield); 200 μm
(immunofluorescence). (C,D) Representative flow cytometry plot (C) and
quantification (D) of mean fluorescence intensity of KDR and PDGFRα at
day 5 for control versus TMEM88 KD populations. n=3-7 per group. Error
bars represent s.e.m. *P<0.05.
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DISCUSSION
Using functional assays in vitro and in vivo, this study shows that
TMEM88 is required for development of cardiomyocytes from the
multilineage cardiovascular progenitor cells. A previous study by
Lee et al. has shown that TMEM88 is a negative regulator of Wnt/β-
catenin signaling (Lee et al., 2010), and we verified enhanced β-
catenin activity after TMEM88 KD in our hESC differentiation
system. Array and epigenetic analysis of TMEM88 shows that this
gene is highly induced (~7500-fold) during the transition from
mesoderm to the CVP and has the chromatin signature emblematic
of genes involved in mediating cell fate decisions. During zebrafish
heart development, tmem88a marks the bilateral heart fields in the
ventrolateral mesoderm. Knockdown of TMEM88 blocks
development of the CVP in vitro at least in part because of increased
Wnt/β-catenin signaling. Furthermore, in the absence of TMEM88,
many of the cells acquire a functional endothelial phenotype in vitro.
Cumulatively, these data suggest that TMEM88 mediates a cell fate
decision in the pre-cardiac mesoderm that defines the onset of
cardiomyocyte specification through inhibition of Wnt signaling.
In a parallel study using a genetic screen to identify genes de-
regulated after depletion of Gata5 and Gata6 in zebrafish, Novikov
and Evans (Novikov and Evans, 2013) also identified Tmem88 as
a key regulatory molecule during heart development. Using
transgenic reporter fish analyzed at 51 hpf, they showed that the
total number of atrial and ventricular cardiomyocytes was
significantly reduced in Tmem88 morpholino-treated zebrafish
compared with controls. A failure to generate sufficient
cardiomyocytes ultimately results in subsequent morphological
issues, such as looping defects, in vivo.
In the current study, TMEM88 is identified as a protein required
for development of the cardiovascular progenitor cell and fits the
model surrounding proteins that mediate the specification of cell
fates. We have previously (Paige et al., 2012) identified a chromatin
and gene expression signature that identifies genes involved in
mediating cell fate choices, which is of particular utility for those
genes that do not fit under the paradigm of transcription factors
mediating key cell fate transitions. TMEM88, a transmembrane
protein, exhibits this signature because the locus shows repressive
chromatin (H3K27me3) during stages at which expression of the
gene would be deleterious to the state or fate of the cell, e.g. by
blocking mesoderm formation. During specification of the CVP, the
repressive chromatin diminishes and the euchromatic H3K4me3
mark increases, resulting in strong activation of the gene precisely
during the period when it functions to mediate restriction into the
cardiovascular lineage.
Lee et al. showed that the C-terminal PDZ binding motif of
TMEM88 binds Disheveled (Dvl) (Lee et al., 2010). In the absence
of TMEM88, binding of Wnt ligands to Frizzled family receptors
results in the recruitment of axin by Dvl to the membrane. This
dissociates the destruction complex and allows β-catenin to
translocate to the nucleus and activate Wnt target genes. If Dvl is
competitively recruited by TMEM88, axin does not translocate to
the membrane, and canonical Wnt signaling is blocked. Consistent
with this hypothesis, our functional assays showed that knockdown
of TMEM88 increases Wnt pathway activity, and addition of the
exogenous Wnt inhibitor XAV-939 partially rescues cardiac
differentiation. Novikov and Evans (Novikov and Evans, 2013)
similarly found that increased Wnt activation exacerbated the
cardiac developmental defects in TMEM88 morpholino-treated
zebrafish, but inhibiting Wnt signaling using heat shock-inducible
Dkk1 rescued the knockdown phenotype.
Downregulation of Wnt signaling has long been known to be
crucial for cardiovascular development (Ueno et al., 2007), and
inclusion of inhibitors (such as XAV-939, IWP or KY02111) in the
post-gastrulation phase of protocols for ESC cardiac differentiation
have become commonplace (Willems et al., 2011; Lian et al., 2012;
Minami et al., 2012). Despite this, the specific mechanisms mediating
endogenous inhibition of Wnt signaling have not been fully
elucidated. We propose that TMEM88, a known negative regulator of
Wnt signaling (Lee et al., 2010), is integral to this process.
Functionally, a failure to express TMEM88 in the pre-cardiac
mesoderm shifts cell fate towards endothelial development. In vitro
data presented here cumulatively show that knockdown of
TMEM88 has no effect on GATA4 or NKX2.5 expression. This
suggests that TMEM88 functions downstream of GATA factors at
the bifurcation of lineages from the pre-cardiac mesoderm to specify
cardiomyocyte development. Recent studies have shown the
requirement for Nkx2.5 in endothelial lineages by fate mapping (Ma
et al., 2008) and functionally in the hemogenic capacity of pre-
cardiac mesoderm (Ferdous et al., 2009) and endocardial-
endothelial derivatives (Nakano et al., 2013). Furthermore, studies
have shown that sustained Wnt/β-catenin signaling mediates the
development of primitive erythroid lineage (Cheng et al., 2008),
which is predominantly what we observe in TMEM88 KD cells in
co-culture with OP9 cells. Further studies will be required to
delineate whether the hemogenic potential observed from TMEM88
KD results from endocardial-endothelial derivatives or reflects a
role of TMEM88 in modulating Wnt/β-catenin signaling during
earlier stages of hemato-endothelial development.
Interestingly, results from Gomez et al. (Gomez et al., 2012) show
that Tmem88 is expressed in the posterior mesoderm in the
developing vasculature of the zebrafish. In situ hybridization data
shown here also indicate that Tmem88 is expressed in the
developing vasculature. Expression of Tmem88 in the anterior to
posterior poles of the lateral plate mesoderm indicate that Tmem88
might be involved in early stages of hemogenic-endothelial
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Fig. 7. Model for TMEM88 function in
cardiovascular development. During heart
development, cells transition through lateral
plate mesoderm before specifying the
cardiovascular lineage. The data described in
this study suggest that TMEM88 acts late in
cardiovascular development after the
cardiovascular progenitor has been specified.
TMEM88 inhibits Wnt signaling in order to drive
development of the cardiomyocyte from the
multilineage CVP. Cells lacking TMEM88
differentiate to an endothelial fate, which
develops as a consequence of sustained high
Wnt signaling activity. D
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development and potentially other mesodermal derivatives.
Expression of Tmem88 clearly increases in the developing
vasculature at stages of development when it is markedly
diminished in heart development. This may indicate that the
endothelium in our hESC system is different from that of the
zebrafish, e.g. resembling endocardial endothelium more than that
of the peripheral vasculature (Nakano et al., 2013). Further studies
are required to clarify this point.
Taken together, we propose a model for TMEM88 in heart
development (Fig. 7). The data presented here suggest that TMEM88
is expressed in the pre-cardiac mesoderm after GATA factors in
NKX2.5 derivatives to specify cardiomyocyte development through
downregulation of canonical Wnt/β-catenin signaling. Endothelial
development occurs in cells depleted of TMEM88 in which sustained
Wnt pathway activity is required for activation of endothelial gene
programs. Cumulatively, this study provides evidence that TMEM88
is indispensable for cardiomyocyte development through its role in
modulating Wnt signaling in the pre-cardiac mesoderm.
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